| Income Statement |
| Total Revenue | 1.35B |
|
| Revenues (USD) | 195.37M |
| Cost of Revenue | 745.73M |
| Gross Profit | 602.29M |
| Operating Expenses | 544.79M |
| Research and Development Expense | 115.37M |
| Selling, General and Administrative Expense | 429.42M |
| Operating Income | 57.50M |
| Interest Expense | 13.61M |
| Income Tax Expense | 4.50M |
| Net Income | 38.58M |
| Net Income Common Stock | 38.58M |
| Net Income Common Stock (USD) | 5.59M |
| Consolidated Income | 43.81M |
| Net Income to Non-Controlling Interests | 5.24M |
| Earning Before Interest & Taxes (EBIT) | 56.68M |
| Earning Before Interest & Taxes (USD) | 8.21M |
| Weighted Average Shares | 118.67M |
| Weighted Average Shares Diluted | 120.44M |
| Balance Sheet |
| Cash and Equivalents | 317.07M |
| Cash and Equivalents (USD) | 45.95M |
| Investments | 216.06M |
| Investments Current | 194.92M |
| Investments Non-Current | 21.14M |
| Trade and Non-Trade Receivables | 326.38M |
| Current Assets | 1.42B |
| Property, Plant & Equipment Net | 91.65M |
| Total Assets | 1.67B |
| Debt Current | 878.00M |
| Total Debt | 1.71B |
| Current Liabilities | 2.71B |
| Debt Non-Current | 836.24M |
| Total Liabilities | 3.57B |
| Shareholders Equity | -1.94B |
| Shareholders Equity (USD) | -280.57M |
| Assets Non-Current | 252.97M |
| Total Debt (USD) | 248.44M |
| Deferred Revenue | 666.97M |
| Goodwill and Intangible Assets | 109.94M |
| Inventory | 116.76M |
| Liabilities Non-Current | 860.71M |
| Trade and Non-Trade Payables | 83.51M |
| Tax Liabilities | 86.53M |